John T. Monyak

872 total citations
23 papers, 652 citations indexed

About

John T. Monyak is a scholar working on Surgery, Gastroenterology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, John T. Monyak has authored 23 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 9 papers in Gastroenterology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in John T. Monyak's work include Gastroesophageal reflux and treatments (9 papers), Eosinophilic Esophagitis (7 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). John T. Monyak is often cited by papers focused on Gastroesophageal reflux and treatments (9 papers), Eosinophilic Esophagitis (7 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). John T. Monyak collaborates with scholars based in United States, United Kingdom and Sweden. John T. Monyak's co-authors include Paul M. Ridker, Jean MacFadyen, Judith Hsia, Mark Sostek, Debra G. Silberg, Donald G. Vidt, Michael D. Cressman, Hans‐Henrik Parving, James R. Sowers and Giuseppe Remuzzi and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

John T. Monyak

21 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John T. Monyak United States	11	449	246	123	110	75	23	652
Songbai Deng China	17	272 0.6×	106 0.4×	55 0.4×	7 0.1×	36 0.5×	44	702
C Hottelart France	10	144 0.3×	126 0.5×	12 0.1×	32 0.3×	168 2.2×	15	433
Hardik Vasnawala India	8	140 0.3×	168 0.7×	17 0.1×	7 0.1×	37 0.5×	12	408
Noriko Sasabe Japan	11	315 0.7×	171 0.7×	6 0.0×	132 1.2×	18 0.2×	16	597
Devin Abrahami Canada	12	172 0.4×	141 0.6×	20 0.2×	105 1.0×	5 0.1×	22	423
I.J.A.M. Jonkers Netherlands	13	223 0.5×	210 0.9×	17 0.1×	8 0.1×	14 0.2×	18	541
Seok Kyu Oh South Korea	19	765 1.7×	162 0.7×	29 0.2×	10 0.1×	34 0.5×	101	1.3k
R Takeda Japan	11	217 0.5×	156 0.6×	15 0.1×	8 0.1×	72 1.0×	26	459
T S G Sehested Denmark	13	233 0.5×	46 0.2×	36 0.3×	70 0.6×	9 0.1×	29	555
Joel Kahn United States	8	494 1.1×	226 0.9×	131 1.1×	2 0.0×	51 0.7×	11	795

Countries citing papers authored by John T. Monyak

Since Specialization

Citations

This map shows the geographic impact of John T. Monyak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Monyak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Monyak more than expected).

Fields of papers citing papers by John T. Monyak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Monyak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Monyak. The network helps show where John T. Monyak may publish in the future.

Co-authorship network of co-authors of John T. Monyak

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Monyak. A scholar is included among the top collaborators of John T. Monyak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Monyak. John T. Monyak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dwyer, Jamie P., Noha Maklad, Ola Vedin, et al.. (2025). Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled Hypertension. Journal of the American Society of Nephrology. 37(2). 299–311. 4 indexed citations

Shehadeh, Naim, Pietro Galassetti, Nayyar Iqbal, et al.. (2024). Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up). The Journal of Clinical Endocrinology & Metabolism. 110(6). 1587–1595. 1 indexed citations

Shehadeh, Naim, Timothy Barrett, Pietro Galassetti, et al.. (2023). Dapagliflozin or Saxagliptin in Pediatric Type 2 Diabetes. NEJM Evidence. 2(12). EVIDoa2300210–EVIDoa2300210. 17 indexed citations

Tamborlane, William V., Raafat Bishai, David H. Geller, et al.. (2022). Once-Weekly Exenatide in Youth With Type 2 Diabetes. Diabetes Care. 45(8). 1833–1840. 60 indexed citations

Pitt, Bertram, Barry Reicher, Richard E. Gilbert, et al.. (2022). Effect Of Saxagliptin On LV Structure And Function In Patients With Type 2 Diabetes And Heart Failure: Results Of Measure-HF. Journal of Cardiac Failure. 28(5). S92–S93.

Tamborlane, William V., Raafat Bishai, David H. Geller, et al.. (2021). 91-LB: Once-Weekly Exenatide in Youth with Type 2 Diabetes: A Pivotal Phase III Randomized Study. Diabetes. 70(Supplement_1). 2 indexed citations

Zeeuw, Dick de, Deborah Anzalone, Valerie A. Cain, et al.. (2015). Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial. The Lancet Diabetes & Endocrinology. 3(3). 181–190. 116 indexed citations

Sharma, Prateek, Nimish Vakil, John T. Monyak, & Debra G. Silberg. (2013). Obesity Does Not Affect Treatment Outcomes With Proton Pump Inhibitors. Journal of Clinical Gastroenterology. 47(8). 672–677. 14 indexed citations

Moses, Robert G., et al.. (2013). A randomized controlled trial of the efficacy and safety of saxagliptin as add‐on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea. Diabetes Obesity and Metabolism. 16(5). 443–450. 45 indexed citations

10.

Pitt, Bertram, Joseph Loscalzo, John T. Monyak, Elinor Miller, & Joel S. Raichlen. (2012). Comparison of Lipid-Modifying Efficacy of Rosuvastatin Versus Atorvastatin in Patients With Acute Coronary Syndrome (from the LUNAR Study). The American Journal of Cardiology. 109(9). 1239–1246. 50 indexed citations

11.

Hsia, Judith, Jean MacFadyen, John T. Monyak, & Paul M. Ridker. (2011). Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin. Journal of the American College of Cardiology. 57(16). 1666–1675. 174 indexed citations

12.

Vidt, Donald G., Paul M. Ridker, John T. Monyak, Martin J. Schreiber, & Michael D. Cressman. (2011). Longitudinal Assessment of Estimated Glomerular Filtration Rate in Apparently Healthy Adults: A Post hoc Analysis from the JUPITER Study (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin). Clinical Therapeutics. 33(6). 717–725. 30 indexed citations

13.

Sharma, Prateek, David A. Johnson, John T. Monyak, & Marta Illueca. (2011). Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors. Alimentary Pharmacology & Therapeutics. 34(4). 487–493. 2 indexed citations

14.

Metz, David C., Gerard J. Fulda, Keith M. Olsen, et al.. (2010). Intravenous esomeprazole pharmacodynamics in critically ill patients. Current Medical Research and Opinion. 26(5). 1141–1148. 6 indexed citations

15.

Sharma, Prateek, Hashem B. El‐Serag, David A. Johnson, John T. Monyak, & Marta Illueca. (2008). Lower Rates of Healing of Erosive Esophagitis (EE) in Nonwhite GERD Patients. The American Journal of Gastroenterology. 103. S25–S25. 1 indexed citations

16.

Metz, David C., Mark Sostek, Philippe Ruszniewski, et al.. (2007). Effects of Esomeprazole on Acid Output in Patients With Zollinger-Ellison Syndrome or Idiopathic Gastric Acid Hypersecretion. The American Journal of Gastroenterology. 102(12). 2648–2654. 48 indexed citations

17.

Pisegna, Joseph R., Mark Sostek, John T. Monyak, & Philip B. Miner. (2007). Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults. Alimentary Pharmacology & Therapeutics. 27(6). 483–490. 10 indexed citations

18.

Katz, Philip O., et al.. (2006). Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis. Alimentary Pharmacology & Therapeutics. 25(5). 617–628. 55 indexed citations

19.

Monyak, John T., et al.. (1994). Statistical Analysis of Turbine Engine Diagnostic (TED) Field Test Data. Defense Technical Information Center (DTIC). 3 indexed citations

20.

Shapiro, Arnold F., Bruce Stuart, N. Edward Coulson, & John T. Monyak. (1991). TIlE DISTRIBUTION OF PRESCRIPTION DRUG USE BY THE ELDERLY - THE PACE EXPERIENCE. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact